Bronchiolitis Obliterans Syndrome Global Market Report 2025
상품코드:1764268
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
폐쇄성 기관지염 증후군 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 22억 3,000만 달러로 성장할 전망이며, CAGR은 8.9%로 성장이 예측됩니다. 예측 기간의 성장은 폐 이식 수술 세계적 증가, BOS에 대한 표적 치료 파이프라인 확대, 희귀 질병에 대한 정부 및 민간 자금 증가, 공동 연구 및 라이선스 계약 증가, 개별화 의료 및 바이오마커에 의한 접근법에 대한 수요의 증가에 기인하고 있습니다. 이 기간에 예상되는 주요 동향으로는 흡입 약물 전달 기술의 진보, 폐진단에서 인공지능 통합, 정밀의료에서 기술을 활용한 진보, 바이오 인포매틱스 및 임상검사 분석 개발, 면역조절요법의 혁신 등이 있습니다.
폐 이식 증가는 향후 몇 년 동안 폐쇄성 기관지염 증후군(BOS) 시장의 성장을 가속할 것으로 예측됩니다. 폐 이식은 호흡 기능을 강화하기 위해 질환 또는 기능 부전 폐를 기증자의 건강한 폐와 대체하는 외과적 처치입니다. 폐 이식의 증가는 성공률을 향상시키고 합병증을 감소시킨 외과적 기술의 진보에 기인하고 있으며, 이 처치는 보다 안전하고 보다 널리 환자에게 제공되게 되었습니다. BOS가 진행한 환자에게 폐 이식은 폐 기능을 회복시키고 호흡곤란을 완화하는 효과적인 치료법입니다. 예를 들면, 2025년 1월, 미국을 거점으로 하는 비영리 과학 및 교육 단체인 Organ Procurement and Transplantation Network(장기 조달 및 이식 네트워크)는, 폐 이식의 비율이 가장 높은 성장을 나타내, 2023년의 3,026건에서 2024년에는 3,340건으로 10.4% 증가했다고 보고했습니다. 이처럼 폐이식 수술 건수 증가가 폐쇄성 기관지염 증후군 시장 확대에 크게 기여하고 있습니다.
임상 검사 건수 증가가 향후 수년간 폐쇄성 기관지염 증후군(BOS) 시장의 성장을 견인할 것으로 예상되고 있습니다. 임상 검사란 약제, 장치, 처치, 행동요법 등 의료개입의 안전성, 유효성, 효과를 평가하기 위해 인간을 대상으로 실시되는 조사연구입니다. 이러한 임상 검사의 증가는 개별화 의료에 대한 수요 증가에 힘입어 표적 치료 및 유전자 기반 치료를 검증하기 위한 더 많은 연구가 필요합니다. BOS의 맥락에서 임상 검사는 염증을 억제하고 폐 기능을 유지하는 것을 목적으로 한 새로운 치료법 평가에 중요한 역할을 수행하는 동시에 질환의 진행과 치료의 안전성에 대한 이해를 진행한다. 예를 들면, 영국을 거점으로 하는 산업 단체인 영국 제약 공업 협회(ABPI)는 2023년 11월, 영국에서 개시된 산업 주최의 임상 검사수가 4.3% 증가해, 2021년의 394건에서 2022년에는 411건으로 증가했다고 보고하고 있습니다. 따라서 임상 검사의 성장은 폐쇄성 기관지염 증후군 시장의 확대에 크게 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 폐쇄성 기관지염 증후군 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 폐쇄성 기관지염 증후군 시장 : 성장률 분석
세계의 폐쇄성 기관지염 증후군 시장 실적 : 규모 및 성장(2019-2024년)
세계의 폐쇄성 기관지염 증후군 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 폐쇄성 기관지염 증후군 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 폐쇄성 기관지염 증후군 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
의약품
산소요법
폐 이식
세계의 폐쇄성 기관지염 증후군 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
폐기능 검사
화상 검사
폐 생검
기타
세계의 폐쇄성 기관지염 증후군 시장 : 질환 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
급성
만성
세계의 폐쇄성 기관지염 증후군 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
진단센터
기타
세계의 폐쇄성 기관지염 증후군 시장 : 의약품별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
면역억제제
코르티코스테로이드
항생제
기관지 확대약
항염증제
세계의 폐쇄성 기관지염 증후군 시장 : 산소 요법별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
지속 산소 요법
간헐 산소 요법
휴대용 산소 요법
고압 산소 요법
세계의 폐쇄성 기관지염 증후군 시장 : 폐 이식별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
편폐 이식
양폐 이식
생체폐 이식
재이식
제7장 지역별 및 국가별 분석
세계의 폐쇄성 기관지염 증후군 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 폐쇄성 기관지염 증후군 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
폐쇄성 기관지염 증후군 시장 : 경쟁 구도
폐쇄성 기관지염 증후군 시장 : 기업 프로파일
Pfizer Inc.
Boehringer Ingelheim
University of California Health
Texas Children's Hospital
Incyte Corporation
제31장 기타 주요 기업 및 혁신 기업
Apollo Hospitals
Mallinckrodt Pharmaceuticals plc
Zambon Company SpA
Fortis Healthcare
St. Louis Children's Hospital
Mayo Foundation for Medical Education and Research
Medicover Hospitals
Renovion Inc.
Mereo BioPharma Group PLC
OrphAI Therapeutics
Koutif Therapeutics
ArkBio
Altavant Sciences
Breath Therapeutics
University of Alberta Hospital
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
폐쇄성 기관지염 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
폐쇄성 기관지염 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
폐쇄성 기관지염 증후군 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Bronchiolitis obliterans syndrome (BOS) is a chronic, progressive lung condition characterized by inflammation and scarring that lead to the narrowing of the small airways. It commonly occurs as a complication following lung or stem cell transplantation, signaling chronic graft rejection. Early diagnosis of BOS is vital to initiate timely treatment, slow disease progression, and preserve lung function.
The primary treatment options for bronchiolitis obliterans syndrome include medication, oxygen therapy, and lung transplantation. Medications help manage BOS by reducing inflammation, slowing disease advancement, and enhancing lung performance. Diagnosis involves various methods such as pulmonary function tests, imaging studies, lung biopsies, and others, tailored to different forms of the disease, including acute bronchiolitis and chronic bronchiolitis obliterans syndrome. The treatments are utilized across multiple end users, including hospitals, specialty clinics, diagnostic centers, and other healthcare facilities.
The bronchiolitis obliterans syndrome market research report is one of a series of new reports from The Business Research Company that provides bronchiolitis obliterans syndrome market statistics, including the bronchiolitis obliterans syndrome industry global market size, regional shares, competitors with the bronchiolitis obliterans syndrome market share, detailed bronchiolitis obliterans syndrome market segments, market trends, opportunities, and any further data you may need to thrive in the bronchiolitis obliterans syndrome industry. This bronchiolitis obliterans syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The bronchiolitis obliterans syndrome market size has grown strongly in recent years. It will grow from $1.46 billion in 2024 to $1.59 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. Growth during the historical period can be attributed to the rising incidence of post-transplant complications, increased awareness among healthcare professionals, expanded use of immunosuppressive therapies, a heightened research focus on rare pulmonary conditions, and the growing adoption of advanced diagnostic imaging and lung function testing.
The bronchiolitis obliterans syndrome market size is expected to see strong growth in the next few years. It will grow to $2.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. Growth in the forecast period can be attributed to the global rise in lung transplant procedures, an expanding pipeline of targeted therapies for BOS, increased government and private funding for orphan diseases, growing collaborations and licensing agreements, and a rising demand for personalized medicine and biomarker-based approaches. Key trends expected during this period include progress in inhaled drug delivery technologies, the integration of artificial intelligence in pulmonary diagnostics, technology-enabled advancements in precision medicine, developments in bioinformatics and clinical trial analytics, and innovations in immunomodulatory therapies.
The increasing number of lung transplantations is anticipated to drive the growth of the bronchiolitis obliterans syndrome (BOS) market in the coming years. Lung transplantation is a surgical procedure in which a diseased or non-functioning lung is replaced with a healthy lung from a donor to enhance respiratory function. The rise in lung transplants is attributed to advancements in surgical techniques that have improved success rates and reduced complications, making the procedure safer and more widely available to patients. For individuals with advanced BOS, lung transplantation offers an effective treatment option by restoring lung function and easing breathing difficulties. For example, in January 2025, the Organ Procurement and Transplantation Network, a U.S.-based nonprofit scientific and educational organization, reported that lung transplants experienced the highest proportional growth, rising from 3,026 in 2023 to 3,340 in 2024-an increase of 10.4%. Thus, the rising number of lung transplant procedures is contributing significantly to the expansion of the bronchiolitis obliterans syndrome market.
The rising number of clinical trials is expected to drive the growth of the bronchiolitis obliterans syndrome (BOS) market in the coming years. Clinical trials are research studies conducted in humans to assess the safety, efficacy, and effectiveness of medical interventions, including drugs, devices, procedures, and behavioral therapies. This increase in clinical trials is fueled by the growing demand for personalized medicine, which necessitates more studies to validate targeted and gene-based treatments. In the context of BOS, clinical trials play a crucial role in evaluating new therapies that aim to reduce inflammation and preserve lung function, while also advancing the understanding of disease progression and treatment safety. For instance, in November 2023, the Association of the British Pharmaceutical Industry (ABPI), a UK-based trade group, reported a 4.3% increase in the number of industry-sponsored clinical trials launched in the UK, rising from 394 in 2021 to 411 in 2022. Therefore, the growth in clinical trials is contributing significantly to the expansion of the bronchiolitis obliterans syndrome market.
Leading companies in the bronchiolitis obliterans syndrome (BOS) market are concentrating on the development of advanced treatments such as at-home nebulized therapy to improve medication adherence and slow disease progression through targeted, continuous care. At-home nebulized therapy uses a nebulizer to convert liquid medication into a mist that can be inhaled directly into the lungs, offering a convenient and self-administered option for managing respiratory conditions from home. For example, in March 2023, Renovion, Inc., a U.S.-based clinical-stage pharmaceutical company, introduced ARINA-1, which received Fast Track Designation from the U.S. Food and Drug Administration (FDA). ARINA-1 is designed to prevent the progression of BOS in patients who have undergone bilateral lung transplants. This regulatory recognition highlights the therapy's potential to meet a critical unmet need in transplant medicine. The Fast Track status allows for more frequent interactions with the FDA and prioritizes ARINA-1 for accelerated development and review, reinforcing Renovion's commitment to advancing respiratory care through innovative, patient-centered treatments.
Major players in the bronchiolitis obliterans syndrome market are Pfizer Inc., Boehringer Ingelheim, University of California Health, Texas Children's Hospital, Incyte Corporation, Apollo Hospitals, Mallinckrodt Pharmaceuticals plc, Zambon Company S.p.A., Fortis Healthcare, St. Louis Children's Hospital, Mayo Foundation for Medical Education and Research, Medicover Hospitals, Renovion Inc., Mereo BioPharma Group PLC, OrphAI Therapeutics, Koutif Therapeutics, ArkBio, Altavant Sciences, Breath Therapeutics, University of Alberta Hospital.
North America was the largest region in the bronchiolitis obliterans syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the bronchiolitis obliterans syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bronchiolitis obliterans syndrome market consists of revenues earned by entities providing services such as psychological counseling, patient monitoring and follow-up care, nutritional support, and pulmonary rehabilitation. The market value includes the value of related goods sold by the service provider or included within the service offering. The bronchiolitis obliterans syndrome market also includes sales of high-resolution CT (HRCT) scanner, oxygen concentrators, flexible bronchoscope, and invasive ventilators. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bronchiolitis Obliterans Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bronchiolitis obliterans syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bronchiolitis obliterans syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bronchiolitis obliterans syndrome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Medication; Oxygen Therapy; Lung Transplant
2) By Diagnosis: Pulmonary Function Tests; Imaging Tests; Lung Biopsy; Other Diagnosis
3) By Disease Type: Acute Bronchiolitis; Chronic Bronchiolitis Obliterans Syndrome
4) By End-User: Hospitals; Specialty Clinics; Diagnostic Centers; Other End-Users
Subsegments:
1) By Medication: Immunosuppressants; Corticosteroids; Antibiotics; Bronchodilators; Anti-Inflammatory Agents
3. Bronchiolitis Obliterans Syndrome Market Trends And Strategies
4. Bronchiolitis Obliterans Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Bronchiolitis Obliterans Syndrome Growth Analysis And Strategic Analysis Framework
5.1. Global Bronchiolitis Obliterans Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bronchiolitis Obliterans Syndrome Market Growth Rate Analysis
5.4. Global Bronchiolitis Obliterans Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bronchiolitis Obliterans Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bronchiolitis Obliterans Syndrome Total Addressable Market (TAM)
6.1. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medication
Oxygen Therapy
Lung Transplant
6.2. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pulmonary Function Tests
Imaging Tests
Lung Biopsy
Other Diagnosis
6.3. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Bronchiolitis
Chronic Bronchiolitis Obliterans Syndrome
6.4. Global Bronchiolitis Obliterans Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Diagnostic Centers
Other End-Users
6.5. Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunosuppressants
Corticosteroids
Antibiotics
Bronchodilators
Anti-Inflammatory Agents
6.6. Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Continuous Oxygen Therapy
Intermittent Oxygen Therapy
Portable Oxygen Therapy
Hyperbaric Oxygen Therapy
6.7. Global Bronchiolitis Obliterans Syndrome Market, Sub-Segmentation Of Lung Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single Lung Transplant
Double Lung Transplant
Living Donor Lung Transplant
Retransplantation
7. Bronchiolitis Obliterans Syndrome Market Regional And Country Analysis
7.1. Global Bronchiolitis Obliterans Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bronchiolitis Obliterans Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bronchiolitis Obliterans Syndrome Market
9.1. China Bronchiolitis Obliterans Syndrome Market Overview
9.2. China Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bronchiolitis Obliterans Syndrome Market
10.1. India Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bronchiolitis Obliterans Syndrome Market
11.1. Japan Bronchiolitis Obliterans Syndrome Market Overview
11.2. Japan Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bronchiolitis Obliterans Syndrome Market
12.1. Australia Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bronchiolitis Obliterans Syndrome Market
13.1. Indonesia Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bronchiolitis Obliterans Syndrome Market
14.1. South Korea Bronchiolitis Obliterans Syndrome Market Overview
14.2. South Korea Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bronchiolitis Obliterans Syndrome Market
15.1. Western Europe Bronchiolitis Obliterans Syndrome Market Overview
15.2. Western Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bronchiolitis Obliterans Syndrome Market
16.1. UK Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.1. Spain Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bronchiolitis Obliterans Syndrome Market
21.1. Eastern Europe Bronchiolitis Obliterans Syndrome Market Overview
21.2. Eastern Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bronchiolitis Obliterans Syndrome Market
22.1. Russia Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bronchiolitis Obliterans Syndrome Market
23.1. North America Bronchiolitis Obliterans Syndrome Market Overview
23.2. North America Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bronchiolitis Obliterans Syndrome Market
24.1. USA Bronchiolitis Obliterans Syndrome Market Overview
24.2. USA Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bronchiolitis Obliterans Syndrome Market
26.1. South America Bronchiolitis Obliterans Syndrome Market Overview
26.2. South America Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bronchiolitis Obliterans Syndrome Market
27.1. Brazil Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bronchiolitis Obliterans Syndrome Market
28.1. Middle East Bronchiolitis Obliterans Syndrome Market Overview
28.2. Middle East Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bronchiolitis Obliterans Syndrome Market
29.1. Africa Bronchiolitis Obliterans Syndrome Market Overview
29.2. Africa Bronchiolitis Obliterans Syndrome Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bronchiolitis Obliterans Syndrome Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bronchiolitis Obliterans Syndrome Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bronchiolitis Obliterans Syndrome Market Competitive Landscape And Company Profiles
